Literature DB >> 12040444

Amplification of AML1 gene is present in childhood acute lymphoblastic leukemia but not in adult, and is not associated with AML1 gene mutation.

D Penther1, C Preudhomme, P Talmant, C Roumier, A Godon, F Méchinaud, N Milpied, R Bataille, H Avet-Loiseau.   

Abstract

The AML1/CBFA2/RUNX1 gene is the target of many recurrent translocations seen in different leukemia subtypes. The t(12;21)(p13;q22) is the most frequent translocation observed in childhood B acute lymphoblastic leukemia (ALL), occurring in 20% to 25% of cases. In adult ALL this rearrangement is scarce. Another route of AML1deregulation could be point mutations in the runt domain. We now report on AML1amplification in two cases of childhood ALL, found in a series of 107 consecutive children with B-lineage ALL analyzed by fluorescence in situ hybridization (FISH). A parallel analysis of 42 adult B-ALL failed to detect any AML1 rearrangement by FISH. The two patients with AML1 amplification were further analyzed using molecular techniques. SSCP analysis did not detect any mutation. Furthermore, direct sequencing of the cDNA did not reveal any mutation. In conclusion, AML1amplification seems to be observed only in childhood ALL and is not associated with AML1 gene mutation. Other mechanisms, such as gene dosage effects could be hypothesized.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12040444     DOI: 10.1038/sj.leu.2402479

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  Genetic aberrations in childhood acute lymphoblastic leukaemia: application of high-density single nucleotide polymorphism array.

Authors:  Sarina Sulong
Journal:  Malays J Med Sci       Date:  2010-07

2.  CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression.

Authors:  Christian Schürch; Carsten Riether; Matthias S Matter; Alexandar Tzankov; Adrian F Ochsenbein
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

Review 3.  Cell cycle and developmental control of hematopoiesis by Runx1.

Authors:  Alan D Friedman
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

4.  AML1 amplification and 17q25 deletion in a case of childhood acute lymphoblastic leukemia.

Authors:  Tuna Gulten; Tahsin Yakut; Mutlu Karkucak; Birol Baytan; Adalet Meral Guneş
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

5.  Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity.

Authors:  Teija L T Aho; Jouko Sandholm; Katriina J Peltola; Yoshiaki Ito; Päivi J Koskinen
Journal:  BMC Cell Biol       Date:  2006-05-09       Impact factor: 4.241

6.  ETV6-RUNX1 Rearrangement in Tunisian Pediatric B-Lineage Acute Lymphoblastic Leukemia.

Authors:  Abir Gmidène; Hatem Elghezal; Hlima Sennana; Yosra Ben Youssef; Balkiss Meddeb; Moez Elloumi; Abderrahim Khlif; Ali Saad
Journal:  Adv Hematol       Date:  2009-12-22

7.  An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.

Authors:  C J Harrison; A V Moorman; C Schwab; A J Carroll; E A Raetz; M Devidas; S Strehl; K Nebral; J Harbott; A Teigler-Schlegel; M Zimmerman; N Dastuge; A Baruchel; J Soulier; M-F Auclerc; A Attarbaschi; G Mann; B Stark; G Cazzaniga; L Chilton; P Vandenberghe; E Forestier; I Haltrich; S C Raimondi; M Parihar; J-P Bourquin; J Tchinda; C Haferlach; A Vora; S P Hunger; N A Heerema; O A Haas
Journal:  Leukemia       Date:  2013-10-29       Impact factor: 11.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.